ORGS — Orgenesis Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.56m
- $17.16m
- $1.04m
Australia's Dotz Nano soars on collaboration with U.S.' Orgenesis unit
Brief: Orgenesis Inc Announces $14.8 Mln Private Placement
Orgenesis Inc reports results for the quarter ended in December - Earnings Summary
Orgenesis Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Orgenesis Reaches Next Milestone In Collaboration With Hospital Infantil Universitario Niño Jesús In Madrid
Brief: Orgenesis And Johns Hopkins University Collaborate For Creation Of The Maryland Center For Cell Therapy Manufacturing
Brief: Orgenesis And Theracell Joint Venture To Receive Up To €32 Mln From Greek Government
Brief: Orgenesis Announces Collaboration With Tel Aviv Sourasky Medical Center To Advance Development Of Cell And Gene And Therapies
Orgenesis Inc reports results for the quarter ended in September - Earnings Summary
Orgenesis Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Orgenesis Announces Collaboration Agreement With Savicell To License And Deploy Its ImmunoBiopsy Platform
Orgenesis Inc reports results for the quarter ended in June - Earnings Summary
Orgenesis Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Orgenesis Achieves Multiple Ranpirnase Development Milestones
Brief: Orgenesis Announces Use Of The Tissue Genesis Icellator® In A Hospital For Special Surgery Clinical Study For Rotator Cuff Repair
Orgenesis Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Peloton, ChemoCentryx, F-star Therapeutics
Brief: Orgenesis Reports Q1 Revenue Of $9.4 Million
U.S. STOCKS ON THE MOVE-Fastly, Avid Technology, PureCycle Tech